Article(id=1330224867099652733, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330224864159445597, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.01.003, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1634054400000, receivedDateStr=2021-10-13, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795079922699, onlineDateStr=2026-11-19, pubDate=1641744000000, pubDateStr=2022-01-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795079922699, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795079922699, creator=13701087609, updateTime=1795079922699, updator=13701087609, issue=Issue{id=1330224864159445597, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='1', pageStart='1', pageEnd='104', issueExtLink='null', onlineDate='null', pubDate='1641744000000', pubDateStr='2022-01-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795079921998, creator='13701087609', updateTime=1795084657767, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330244727875678840, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330224864159445597, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330244727875678841, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330224864159445597, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=11, endPage=14, ext={EN=ArticleExt(id=1330224868760597118, articleId=1330224867099652733, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Progress on the application of secukinumab in the treatment of rheumatism, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

In recent years, with the development and clinical application of more and more efficient and safe biological agents, great progress has been made in the treatment of rheumatic immune diseases. As a new biological agent, secukinumab has the characteristics of rapid onset, significant curative effect and high safety. It can significantly improve the prognosis and quality of life of patients. This paper reviewed the application of secukinumab in the treatment of rheumatism, mainly focusing on the application and curative effect of ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis and other diseases, in order to provide reference for clinical diagnosis and treatment.

, authors=Xiaoqing WANG1, Guangtao XIA2, *, authorsList=Xiaoqing WANG, Guangtao XIA, authorCompany=null, correspAuthors=Guangtao XIA, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330224868999672447, articleId=1330224867099652733, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=司库奇尤单抗在风湿病治疗中的应用进展, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

近年来,随着越来越多高效、安全的生物制剂被研制并应用于临床,针对风湿免疫病的治疗取得重大进展,而司库奇尤单抗(secukinumab)作为一种新型生物制剂,具有起效迅速、疗效显著、安全性高的特点,可显著改善患者预后,提高患者生活质量。现就司库奇尤单抗在风湿病,尤其在强直性脊柱炎(ankylosing spondylitis)、银屑病关节炎(psoriatic arthritis)、类风湿关节炎(rheumatoid arthritis)等疾病中的应用及疗效作一综述,以期为临床诊治提供参考。

, authors=王晓庆1, 夏光涛2, *, authorsList=王晓庆, 夏光涛, authorCompany=null, correspAuthors=夏光涛, authorNote=

王晓庆,主治医师,研究方向:关节炎的治疗。

, correspAuthorsNote=
夏光涛,主任医师,研究方向:风湿免疫病的诊治。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=TkoVl+eCCZZag/L8biZ8gw==, magXml=BAr8qVlqZZNpjRMmAz28NA==, pdfUrl=null, pdf=3U5ckSUxxl0R163yEc2nFw==, pdfFileSize=1655617, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=/PpWweDnkx8u0mPIKKKuRA==, mapNumber=null, fund=null)}, authors=[Author(id=1330224869368771207, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330224869452657289, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, authorId=1330224869368771207, language=EN, stringName=Xiaoqing WANG, firstName=Xiaoqing, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Rheumatology and Immunology, Gaomi People's Hospital, Gaomi 261500, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330224869523960458, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, authorId=1330224869368771207, language=CN, stringName=王晓庆, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.高密市人民医院风湿免疫科,山东 高密 261500, bio={"content":"

王晓庆,主治医师,研究方向:关节炎的治疗。

"}, bioImg=null, bioContent=

王晓庆,主治医师,研究方向:关节炎的治疗。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330224869196804736, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, xref=1., ext=[AuthorCompanyExt(id=1330224869205193345, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, companyId=1330224869196804736, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Rheumatology and Immunology, Gaomi People's Hospital, Gaomi 261500, Shandong Province, China), AuthorCompanyExt(id=1330224869217776258, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, companyId=1330224869196804736, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.高密市人民医院风湿免疫科,山东 高密 261500)])]), Author(id=1330224869591069324, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330224869666566798, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, authorId=1330224869591069324, language=EN, stringName=Guangtao XIA, firstName=Guangtao, middleName=null, lastName=XIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330224869721092751, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, authorId=1330224869591069324, language=CN, stringName=夏光涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330224869289079427, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, xref=2., ext=[AuthorCompanyExt(id=1330224869301662340, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, companyId=1330224869289079427, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China), AuthorCompanyExt(id=1330224869305856645, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, companyId=1330224869289079427, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021)])])], keywords=[Keyword(id=1330224869796590224, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, language=EN, orderNo=1, keyword=secukinumab), Keyword(id=1330224869855310481, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, language=EN, orderNo=2, keyword=ankylosing spondylitis), Keyword(id=1330224869909836434, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, language=EN, orderNo=3, keyword=psoriatic arthritis), Keyword(id=1330224869972750995, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, language=EN, orderNo=4, keyword=rheumatoid arthritis), Keyword(id=1330224870035665556, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, language=CN, orderNo=1, keyword=司库奇尤单抗), Keyword(id=1330224870098580117, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, language=CN, orderNo=2, keyword=强直性脊柱炎), Keyword(id=1330224870161494678, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, language=CN, orderNo=3, keyword=银屑病关节炎), Keyword(id=1330224870241186455, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, language=CN, orderNo=4, keyword=类风湿关节炎)], refs=[Reference(id=1330224870446707353, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Nirula A, Nilsen J, Klekotka P, et al. Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases[J]. Rheumatology, 2016, 55(2): ii43-ii55., articleTitle=null, refAbstract=null), Reference(id=1330224870526399130, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Patel DD, Lee DM, Kolbinger F, et al. Effect of IL-17A blockade with secukinumab in autoimmune diseases[J]. Ann Rheum Dis, 2013, 72: ii116-ii123., articleTitle=null, refAbstract=null), Reference(id=1330224870580925083, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Martin DA, Towne JE, Kricorian G, et al. The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings[J]. J Invest Dermatol, 2013, 133(1): 17-26., articleTitle=null, refAbstract=null), Reference(id=1330224870635451036, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Mahmood F, Helliwell P. Ankylosing spondylitis: a review[J]. Eur Med J, 2017, 2(4): 134-139., articleTitle=null, refAbstract=null), Reference(id=1330224870702559901, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Braun J, Sieper J. Ankylosing spondylitis[J]. Lancet, 2007, 369(9570): 1379-1390., articleTitle=null, refAbstract=null), Reference(id=1330224870761280158, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=van der Heijde D, Ramiro S, Landewe R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis[J]. Ann Rheum Dis, 2017, 76(6): 978-991., articleTitle=null, refAbstract=null), Reference(id=1330224870849360543, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Ward MM, Deodhar A, Akl EA, et al. American college of rheumatology/spondylitis association of America/spondyloarthritis research and treatment network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis[J]. Arthritis Rheumatol, 2016, 68(2): 282298., articleTitle=null, refAbstract=null), Reference(id=1330224870912275104, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Antonelli M, Khan MA, Magrey MN. Differential adverse events between TNF-α inhibitors and IL-17 axis inhibitors for the treatment of spondyloarthritis[J]. Curr Treatm Opt Rheumatol, 2015, 1(2): 239-254., articleTitle=null, refAbstract=null), Reference(id=1330224870966801057, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Magrey M, Bozyczko M, Wolin D, et al. A pilot study to assess the feasibility of a web-based survey to examine patient-reported symptoms and satisfaction in patients with ankylosing spondylitis receiving secukinumab[J]. Drugs Real World Outcomes, 2019, 6(2): 83-91., articleTitle=null, refAbstract=null), Reference(id=1330224871029715618, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Martinis F, Caimmi C, Carletto A, et al. AB0833 real-world efficacy and safety of secukinumab: data from Verona's cohort[J]. Ann Rheum Dis, 2018, 77(2): 1544-1545., articleTitle=null, refAbstract=null), Reference(id=1330224871084241571, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Robertson J, Tindell A, Crosbie D, et al. 190 real-world experience of secukinumab for psoriatic arthritis and axial spondyloarthritis[J]. Rheumatology, 2018, 57(3): 120., articleTitle=null, refAbstract=null), Reference(id=1330224871151350436, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Gentileschi S, Vitale A, Rigante D, et al. Prompt clinical response to secukinumab in patients with axial spondyloarthritis: real life observational data from three Italian referral centers[J]. Isr Med Assoc J, 2018, 20(7): 438-441., articleTitle=null, refAbstract=null), Reference(id=1330224871222653605, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Veale DJ, Fearon U. The pathogenesis of psoriatic arthritis[J]. Lancet, 2018, 391(10136): 2273-2284., articleTitle=null, refAbstract=null), Reference(id=1330224871293956774, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Gossec L, Baraliakos X, Kerschbaumer A, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update[J]. Ann Rheum Dis, 2020, 79(6): 700-712., articleTitle=null, refAbstract=null), Reference(id=1330224871348482727, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Raposo I, Torres T. Nail psoriasis as a predictor of the development of psoriatic arthritis[J]. Actas Dermosifiliogr, 2015, 106(6): 452-457., articleTitle=null, refAbstract=null), Reference(id=1330224871419785896, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Gossec L, Smolen JS, Ramiro S, et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update[J]. Ann Rheum Dis, 2016, 75(3): 499-510., articleTitle=null, refAbstract=null), Reference(id=1330224873030398634, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=陆晓鸥, 王海彦, 曹馨元, 等. 司库奇尤单抗300 mg和150 mg治疗银屑病性关节炎长期疗效比较meta分析[J]. 中国麻风皮肤病杂志, 2020, 36(8): 454-460., articleTitle=null, refAbstract=null), Reference(id=1330224873105896107, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=McInnes IB, Behrens F, Mease PJ, et al. Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): adouble-blind, parallel-group, randomised, active-controlled, phase 3b trial[J]. Lancet, 2020, 395(10235): 1496-1505., articleTitle=null, refAbstract=null), Reference(id=1330224873173004972, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Wasilewska A, Winiarska M, Olszewska M, et al. Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases[J]. Adv Dermatol Allergol, 2016, 33(4): 247-252., articleTitle=null, refAbstract=null), Reference(id=1330224873240113837, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会皮肤性病学分会. 中国银屑病生物治疗专家共识(2019)[J]. 中华皮肤科杂志, 2019, 52(12): 863-871., articleTitle=null, refAbstract=null), Reference(id=1330224873328194222, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Reich K, Puig L, Szepietowski JC, et al. Secukinumab dosing optimization in patients with moderate-to-severe plaque psoriasis: results from the randomized, open-label OPTIMISE study[J]. Br J Dermatol, 2020, 182(2): 304-315., articleTitle=null, refAbstract=null), Reference(id=1330224873395303087, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang L, Yang H, Chen Q, et al. Adverse drug events observed with 150 mg vs. 300 mg secukinumab for the treatment of moderate to severe plaque psoriasis: a systematic review and metanalysis[J]. Medicine, 2019, 98(2): 40-42., articleTitle=null, refAbstract=null), Reference(id=1330224873462411952, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Aletaha D, Smolen IS. Diagnosis management of rheumatoid arthritis: a review[J]. JAMA, 2018, 320(13): 1360-1372., articleTitle=null, refAbstract=null), Reference(id=1330224873542103729, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Blanco FJ, Möricke R, Dokoupilova E, et al. Secukinumab in active rheumatoid arthritis: a phase Ⅲ randomized, double-blind, active comparator-and placebo-controlled study[J]. Arthritis Rheumatol, 2017, 69(6): 1144-1153., articleTitle=null, refAbstract=null), Reference(id=1330224873605018290, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Dokoupilová E, Aelion J, Takeuchi T, et al. Secukinumab after anti-tumour necrosis factor-α therapy: a phase Ⅲ study in active rheumatoid arthritis[J]. Scand J Rheumatol, 2018, 47(4): 276-281., articleTitle=null, refAbstract=null)], funds=[Fund(id=1330224870329266840, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, awardId=ZR2021MH265, language=CN, fundingSource=山东省自然科学基金面上项目:miR-326与Th17/Treg、APE、Ref-1相互作用对自身免疫性肝炎影响研究(ZR2021MH265), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1330224869196804736, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, xref=1., ext=[AuthorCompanyExt(id=1330224869205193345, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, companyId=1330224869196804736, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Rheumatology and Immunology, Gaomi People's Hospital, Gaomi 261500, Shandong Province, China), AuthorCompanyExt(id=1330224869217776258, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, companyId=1330224869196804736, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.高密市人民医院风湿免疫科,山东 高密 261500)]), AuthorCompany(id=1330224869289079427, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, xref=2., ext=[AuthorCompanyExt(id=1330224869301662340, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, companyId=1330224869289079427, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China), AuthorCompanyExt(id=1330224869305856645, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, companyId=1330224869289079427, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.01.003, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.01.003, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.01.003, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.01.003, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1641744000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
司库奇尤单抗在风湿病治疗中的应用进展
王晓庆 1 , 夏光涛 2, *
世界临床药物 | 医药专论 2022,43(1): 11-14
收起
收藏切换
世界临床药物 |医药专论 2022 , 43 (1) : 11 -14
司库奇尤单抗在风湿病治疗中的应用进展
全屏
[Author(id=1330224869368771207, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330224869452657289, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, authorId=1330224869368771207, language=EN, stringName=Xiaoqing WANG, firstName=Xiaoqing, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Rheumatology and Immunology, Gaomi People's Hospital, Gaomi 261500, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330224869523960458, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, authorId=1330224869368771207, language=CN, stringName=王晓庆, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.高密市人民医院风湿免疫科,山东 高密 261500, bio={"content":"

王晓庆,主治医师,研究方向:关节炎的治疗。

"}, bioImg=null, bioContent=

王晓庆,主治医师,研究方向:关节炎的治疗。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330224869196804736, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, xref=1., ext=[AuthorCompanyExt(id=1330224869205193345, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, companyId=1330224869196804736, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Rheumatology and Immunology, Gaomi People's Hospital, Gaomi 261500, Shandong Province, China), AuthorCompanyExt(id=1330224869217776258, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, companyId=1330224869196804736, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.高密市人民医院风湿免疫科,山东 高密 261500)])]), Author(id=1330224869591069324, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330224869666566798, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, authorId=1330224869591069324, language=EN, stringName=Guangtao XIA, firstName=Guangtao, middleName=null, lastName=XIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330224869721092751, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, authorId=1330224869591069324, language=CN, stringName=夏光涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330224869289079427, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, xref=2., ext=[AuthorCompanyExt(id=1330224869301662340, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, companyId=1330224869289079427, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China), AuthorCompanyExt(id=1330224869305856645, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330224867099652733, companyId=1330224869289079427, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021)])])]
王晓庆1, 夏光涛2, *
作者信息
  • 1.高密市人民医院风湿免疫科,山东 高密 261500
  • 2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021
通讯作者:
夏光涛,主任医师,研究方向:风湿免疫病的诊治。
作者简介:

王晓庆,主治医师,研究方向:关节炎的治疗。

Progress on the application of secukinumab in the treatment of rheumatism
Xiaoqing WANG1, Guangtao XIA2, *
Affiliations
  • 1.Department of Rheumatology and Immunology, Gaomi People's Hospital, Gaomi 261500, Shandong Province, China
  • 2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China
出版时间: 2022-01-10 doi: 10.13683/j.wph.2022.01.003
文章导航
收藏切换

近年来,随着越来越多高效、安全的生物制剂被研制并应用于临床,针对风湿免疫病的治疗取得重大进展,而司库奇尤单抗(secukinumab)作为一种新型生物制剂,具有起效迅速、疗效显著、安全性高的特点,可显著改善患者预后,提高患者生活质量。现就司库奇尤单抗在风湿病,尤其在强直性脊柱炎(ankylosing spondylitis)、银屑病关节炎(psoriatic arthritis)、类风湿关节炎(rheumatoid arthritis)等疾病中的应用及疗效作一综述,以期为临床诊治提供参考。

司库奇尤单抗  /  强直性脊柱炎  /  银屑病关节炎  /  类风湿关节炎

In recent years, with the development and clinical application of more and more efficient and safe biological agents, great progress has been made in the treatment of rheumatic immune diseases. As a new biological agent, secukinumab has the characteristics of rapid onset, significant curative effect and high safety. It can significantly improve the prognosis and quality of life of patients. This paper reviewed the application of secukinumab in the treatment of rheumatism, mainly focusing on the application and curative effect of ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis and other diseases, in order to provide reference for clinical diagnosis and treatment.

secukinumab  /  ankylosing spondylitis  /  psoriatic arthritis  /  rheumatoid arthritis
王晓庆, 夏光涛. 司库奇尤单抗在风湿病治疗中的应用进展. 世界临床药物, 2022 , 43 (1) : 11 -14 . DOI: 10.13683/j.wph.2022.01.003
Xiaoqing WANG, Guangtao XIA. Progress on the application of secukinumab in the treatment of rheumatism[J]. World Clinical Drug, 2022 , 43 (1) : 11 -14 . DOI: 10.13683/j.wph.2022.01.003
  • 山东省自然科学基金面上项目:miR-326与Th17/Treg、APE、Ref-1相互作用对自身免疫性肝炎影响研究(ZR2021MH265)
参考文献 引证文献
排序方式:
[1]
Nirula A, Nilsen J, Klekotka P, et al. Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases[J]. Rheumatology, 2016, 55(2): ii43-ii55.
[2]
Patel DD, Lee DM, Kolbinger F, et al. Effect of IL-17A blockade with secukinumab in autoimmune diseases[J]. Ann Rheum Dis, 2013, 72: ii116-ii123.
[3]
Martin DA, Towne JE, Kricorian G, et al. The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings[J]. J Invest Dermatol, 2013, 133(1): 17-26.
[4]
Mahmood F, Helliwell P. Ankylosing spondylitis: a review[J]. Eur Med J, 2017, 2(4): 134-139.
[5]
Braun J, Sieper J. Ankylosing spondylitis[J]. Lancet, 2007, 369(9570): 1379-1390.
[6]
van der Heijde D, Ramiro S, Landewe R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis[J]. Ann Rheum Dis, 2017, 76(6): 978-991.
[7]
Ward MM, Deodhar A, Akl EA, et al. American college of rheumatology/spondylitis association of America/spondyloarthritis research and treatment network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis[J]. Arthritis Rheumatol, 2016, 68(2): 282298.
[8]
Antonelli M, Khan MA, Magrey MN. Differential adverse events between TNF-α inhibitors and IL-17 axis inhibitors for the treatment of spondyloarthritis[J]. Curr Treatm Opt Rheumatol, 2015, 1(2): 239-254.
[9]
Magrey M, Bozyczko M, Wolin D, et al. A pilot study to assess the feasibility of a web-based survey to examine patient-reported symptoms and satisfaction in patients with ankylosing spondylitis receiving secukinumab[J]. Drugs Real World Outcomes, 2019, 6(2): 83-91.
[10]
Martinis F, Caimmi C, Carletto A, et al. AB0833 real-world efficacy and safety of secukinumab: data from Verona's cohort[J]. Ann Rheum Dis, 2018, 77(2): 1544-1545.
[11]
Robertson J, Tindell A, Crosbie D, et al. 190 real-world experience of secukinumab for psoriatic arthritis and axial spondyloarthritis[J]. Rheumatology, 2018, 57(3): 120.
[12]
Gentileschi S, Vitale A, Rigante D, et al. Prompt clinical response to secukinumab in patients with axial spondyloarthritis: real life observational data from three Italian referral centers[J]. Isr Med Assoc J, 2018, 20(7): 438-441.
[13]
Veale DJ, Fearon U. The pathogenesis of psoriatic arthritis[J]. Lancet, 2018, 391(10136): 2273-2284.
[14]
Gossec L, Baraliakos X, Kerschbaumer A, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update[J]. Ann Rheum Dis, 2020, 79(6): 700-712.
[15]
Raposo I, Torres T. Nail psoriasis as a predictor of the development of psoriatic arthritis[J]. Actas Dermosifiliogr, 2015, 106(6): 452-457.
[16]
Gossec L, Smolen JS, Ramiro S, et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update[J]. Ann Rheum Dis, 2016, 75(3): 499-510.
[17]
陆晓鸥, 王海彦, 曹馨元, 等. 司库奇尤单抗300 mg和150 mg治疗银屑病性关节炎长期疗效比较meta分析[J]. 中国麻风皮肤病杂志, 2020, 36(8): 454-460.
[18]
McInnes IB, Behrens F, Mease PJ, et al. Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): adouble-blind, parallel-group, randomised, active-controlled, phase 3b trial[J]. Lancet, 2020, 395(10235): 1496-1505.
[19]
Wasilewska A, Winiarska M, Olszewska M, et al. Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases[J]. Adv Dermatol Allergol, 2016, 33(4): 247-252.
[20]
中华医学会皮肤性病学分会. 中国银屑病生物治疗专家共识(2019)[J]. 中华皮肤科杂志, 2019, 52(12): 863-871.
[21]
Reich K, Puig L, Szepietowski JC, et al. Secukinumab dosing optimization in patients with moderate-to-severe plaque psoriasis: results from the randomized, open-label OPTIMISE study[J]. Br J Dermatol, 2020, 182(2): 304-315.
[22]
Zhang L, Yang H, Chen Q, et al. Adverse drug events observed with 150 mg vs. 300 mg secukinumab for the treatment of moderate to severe plaque psoriasis: a systematic review and metanalysis[J]. Medicine, 2019, 98(2): 40-42.
[23]
Aletaha D, Smolen IS. Diagnosis management of rheumatoid arthritis: a review[J]. JAMA, 2018, 320(13): 1360-1372.
[24]
Blanco FJ, Möricke R, Dokoupilova E, et al. Secukinumab in active rheumatoid arthritis: a phase Ⅲ randomized, double-blind, active comparator-and placebo-controlled study[J]. Arthritis Rheumatol, 2017, 69(6): 1144-1153.
[25]
Dokoupilová E, Aelion J, Takeuchi T, et al. Secukinumab after anti-tumour necrosis factor-α therapy: a phase Ⅲ study in active rheumatoid arthritis[J]. Scand J Rheumatol, 2018, 47(4): 276-281.
2022年第43卷第1期
12
2
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2022.01.003
  • 接收时间:2021-10-13
  • 首发时间:2026-11-19
  • 出版时间:2022-01-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2021-10-13
基金
山东省自然科学基金面上项目:miR-326与Th17/Treg、APE、Ref-1相互作用对自身免疫性肝炎影响研究(ZR2021MH265)
作者信息
    1.高密市人民医院风湿免疫科,山东 高密 261500
    2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021

通讯作者:

夏光涛,主任医师,研究方向:风湿免疫病的诊治。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.01.003
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏